内容紹介
Summary
We report a case of a 74-year-old woman with a left breast tumor with skin infiltration. Luminal type breast cancer with lung, bone, and parasternal lymph node metastases was diagnosed. She received paclitaxel and bevacizumab treatment. After chemotherapy, the lung metastasis and parasternal lymph node metastasis had disappeared, and the breast tumor had shrunk. Mastectomy and axillary lymph node dissection were performed. She has been receiving post-operative endocrine therapy. Paclitaxel and bevacizumab combination therapy is one of the useful treatments for metastatic breast cancer with skin infiltration.
要旨
症例は74歳,女性。皮膚に浸潤した左乳房腫瘤を認め,精査にて肺・骨・傍胸骨リンパ節に転移を伴うLuminal type乳癌と診断した。パクリタキセル+ベバシズマブの薬物治療を開始,遠隔転移巣は消失し,原発巣も縮小した。局所制御目的に乳房切除術と腋窩リンパ節郭清を施行した。術後,内分泌療法を継続し,転移巣は増悪なく経過している。ベバシズマブ併用化学療法にて局所制御目的に手術施行した症例を経験したので報告する。
目次
We report a case of a 74-year-old woman with a left breast tumor with skin infiltration. Luminal type breast cancer with lung, bone, and parasternal lymph node metastases was diagnosed. She received paclitaxel and bevacizumab treatment. After chemotherapy, the lung metastasis and parasternal lymph node metastasis had disappeared, and the breast tumor had shrunk. Mastectomy and axillary lymph node dissection were performed. She has been receiving post-operative endocrine therapy. Paclitaxel and bevacizumab combination therapy is one of the useful treatments for metastatic breast cancer with skin infiltration.
要旨
症例は74歳,女性。皮膚に浸潤した左乳房腫瘤を認め,精査にて肺・骨・傍胸骨リンパ節に転移を伴うLuminal type乳癌と診断した。パクリタキセル+ベバシズマブの薬物治療を開始,遠隔転移巣は消失し,原発巣も縮小した。局所制御目的に乳房切除術と腋窩リンパ節郭清を施行した。術後,内分泌療法を継続し,転移巣は増悪なく経過している。ベバシズマブ併用化学療法にて局所制御目的に手術施行した症例を経験したので報告する。